Developing a Polygenic Risk Score for Weight Gain in People Treated for Psychosis—Application in a Real‐World Setting
Human Psychopharmacology: Clinical and Experimental · 2026-03 · 41 (2)
DOI: 10.1002/hup.70035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, online erschienen am 14.03.2026. Verfasst von Adrian Heald und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Diabetes, Salford Royal Hospital, Salford, UK. Hauptthemen laut MEDLINE: Weight Gain, Antipsychotic Agents, Psychotic Disorders, Multifactorial Inheritance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Genetic factors are thought to play an important role in antipsychotic‐induced weight gain (AIWG). Polygenic risk scores (PRS) could provide a measure of genetic predisposition to antipsychotic drug induced weight gain (AIWG).We conducted a study to examine how a PRS, generated using SNPs, identified from a recent meta‐analysis, related to weight‐change over time in people with first episode‐psychosis.
Methods
The PRS included SNPs in six different genes, identified as having significant associations ( p < 0.05) with AIWG. These were HTR2C rs3813929; MTHFR rs1801133; ADRA2A rs1800544; MC4R rs489693; LEPR rs1137101 and CNR1 rs1049353. An additive PRS and a risk allele based weighted PRS were created based on risk allele counts and presence or absence of risk alleles respectively. The additive PRS was also used to create low/high genetic risk groups for analysis. The association between PRS and weight gain per day (WGPD) in grams/day as well as BMI percentage change (=> 7%) was investigated using regression models.
Results
In multiple regression analysis, the additive PRS significantly predicted AIWG in females (adjusted r 2 = 0.59, B: unstandardised regression coefficient = 24.4 g/day p < 0.05), but not in males. ANCOVA showed that high genetic risk groups had greater WGPD ( p = 0.018), with significant PRS gender interactions driven by markedly higher WGPD in high‐risk females ( p = 0.039). None of the models tested were associated with BMI percentage change.
Conclusion
We report a PRS that is predictive of weight gain in women treated for first episode psychosis, accounting for 59% of the variance daily weight‐gain over time. Validation in an independent cohort is required, as is determining whether it is feasible to apply the PRS prospectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Diabetes, Salford Royal Hospital, Salford, UK.
- The School of Medicine and Manchester Academic Health Sciences Centre, Manchester University, Manchester, UK.
- Sheffield Hallam University, Biomolecular Sciences Research Centre, Sheffield, UK.
- Department of Pharmacology, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.
- Rotherham, Doncaster and South Humber NHS Foundation, Doncaster, UK.
- School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK.
ORCID-Profile: Adrian Heald
Zitieren
APA
Heald, A., Illangasekera, Y., Loureiro, C. M., Shakespeare, M., Jameson, A., Phillipson, A., Reynolds, G. P., & Dalton, C. (2026). Developing a Polygenic Risk Score for Weight Gain in People Treated for Psychosis—Application in a Real‐World Setting. Human Psychopharmacology: Clinical and Experimental, 41(2). https://doi.org/10.1002/hup.70035
Vancouver
Heald A, Illangasekera Y, Loureiro CM, Shakespeare M, Jameson A, Phillipson A, et al. Developing a Polygenic Risk Score for Weight Gain in People Treated for Psychosis—Application in a Real‐World Setting. Human Psychopharmacology: Clinical and Experimental. 2026;41(2). doi:10.1002/hup.70035
BibTeX
@article{Heald2026,
author = {Heald, Adrian and Illangasekera, Yasitha and Loureiro, Camila Marcelino and Shakespeare, Mark and Jameson, Adam and Phillipson, Adrian and Reynolds, Gavin P and Dalton, Caroline},
title = {Developing a Polygenic Risk Score for Weight Gain in People Treated for Psychosis—Application in a Real‐World Setting},
journal = {Human Psychopharmacology: Clinical and Experimental},
year = {2026},
volume = {41},
number = {2},
doi = {10.1002/hup.70035}
}
EUVIMED